New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Teleflex Incorporated
TFX
Shape
US Flag

NYSE

11B

Medical - Instruments & Supplies

Next Earning date - 07 Nov 2024

11B

Medical - Instruments & Supplies

Next Earning date - 07 Nov 2024

236.03USD
Shape1.41 ( 0.60%)
favorite-chart

Relative Strenght

12
favorite-chart

Volume Buzz

-52%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

8%

Quote Panel

Shape
Updated October 12, 2024
1W 1.32 % 1M -4.07 % 3M 7.52 % 1Y 25.29 %

Key Metrics

Shape
  • Market Cap

    11.12B


  • Shares Outstanding

    47.12M


  • Share in Float

    46.98M


  • Dividende

    1.36


  • Earning Date

    07 Nov 2024


  • Price Target

    236.03


  • Average Volume

    371104


  • Beta

    1.156


  • Range

    177.63-257.85


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.teleflex.com


  • Sector

    Healthcare


Fundamentals

Shape

17.29x

P/E Ratio

3.72x

P/S Ratio

2.45x

P/B Ratio

0.4

Debt/Equity

8.8%

Net Margin

$5.6

EPS

How TFX compares to sector?

P/E Ratio

Relative Strength

Shape

TFX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3B

Shape337%

2025-Revenue

$10.74

Shape532%

2025-EPS

$886M

Shape356%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Piper Sandler

upgrade

Previous: Neutral

2024-07-01

Now: Overweight

Morgan Stanley

upgrade

Previous: Equal-Weight

2023-12-04

Now: Overweight

CFRA

upgrade

Previous: Not converted

2023-02-24

Now: Buy

Wells Fargo

downgrade

Previous: Not converted

2022-07-29

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-7%

3.27
vs 3.51

Q4.22

arrow
arrow

-2%

3.52
vs 3.6

Q2.23

arrow
arrow

-9%

3.09
vs 3.39

Q3.23

arrow
arrow

+4%

3.41
vs 3.27

Q4.23

arrow
arrow

+3%

3.64
vs 3.52

Q4.23

arrow
arrow

-4%

3.38
vs 3.52

Q1.24

arrow
arrow

N/A

3.21
vs NA

Q2.24

arrow
arrow

+11%

3.42
vs 3.09

Q3.24

arrow
arrow

-1%

3.39
vs 3.41

Q4.24

arrow
arrow

+17%

3.95
vs 3.38

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-2%

686.8M  vs 700.3M

Q4.22

arrow
arrow

-1%

758M  vs 761.9M

Q2.23

arrow
arrow

+1%

710.9M  vs 704.5M

Q3.23

arrow
arrow

+8%

743.3M  vs 686.8M

Q4.23

arrow
arrow

-2%

746.4M  vs 758M

Q4.23

arrow
arrow

+2%

773.9M  vs 758M

Q1.24

arrow
arrow

NA

737.8M  vs NA

Q2.24

arrow
arrow

+5%

749.7M  vs 710.9M

Q3.24

arrow
arrow

+3%

768.7M  vs 743.3M

Q4.24

arrow
arrow

+7%

826.3M  vs 773.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+3%

0.03
vs 0.03

Q4.22

arrow
arrow

+2%

0.02
vs 0.03

Q2.23

arrow
arrow

+2%

0.02
vs 0.02

Q3.23

arrow
arrow

+3%

0.03
vs 0.02

Q4.23

arrow
arrow

+3%

0.03
vs 0.03

Q4.23

arrow
arrow

+1%

0.01
vs 0.03

Q1.24

arrow
arrow

+0%

0
vs 0.01

Q2.24

arrow
arrow

+2%

0.02
vs 0

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

479

479
vs 519

-8%

Q4.22

arrow
arrow

494

494
vs 479

3%

Q1.23

arrow
arrow

492

492
vs 494

0%

Q2.23

arrow
arrow

487

487
vs 492

-1%

Q3.23

arrow
arrow

482

482
vs 487

-1%

Q4.23

arrow
arrow

480

480
vs 482

0%

Q1.24

arrow
arrow

483

483
vs 480

1%

Q2.24

arrow
arrow

521

521
vs 483

8%

Earnings Growth

Latest News